NBIX Past Earnings image   This NBIX past earnings page last updated 5/6/2022
NBIX Past Earnings
Data adjusted for NBIX split history

PeriodPast Earnings DateAdj. EPS
Q1 20225/4/20220.300
Q4 20212/11/20220.040
Q3 202111/1/20210.640
Q2 20218/3/20210.630
Q1 20215/5/20210.490
Q4 20202/4/20210.910
Q3 202011/9/20200.970
Q2 20208/3/20201.420
Q1 20205/6/20200.820
Q4 20192/4/20201.050
Q3 201911/4/20190.560
Q2 20197/29/20190.320
Q1 20194/29/2019-1.120
Q4 20182/5/20190.19
Q3 201811/5/20180.52
Q2 20187/31/2018-0.07
Q1 20184/30/2018-0.47
Q4 20172/13/20180.07
Q3 201711/1/2017-0.13
Q2 20178/3/2017-0.68
Q1 20175/9/2017-0.9
Q4 20162/14/2017-0.51
Q3 201611/2/2016-0.43
Q2 20168/3/2016-0.46
Q1 20165/5/2016-0.22
Q4 20152/11/2016-0.34
Q3 201510/29/2015-0.4
Q2 20157/29/2015-0.28
Q1 20154/30/2015-0.01
Q4 20142/9/2015-0.26
Q3 201411/3/2014-0.21
Q2 20148/6/2014-0.18
Q1 20144/30/2014-0.17
Q4 201312/31/2013-0.16
Q3 201310/29/2013-0.17
Q2 20137/25/2013-0.18
Q1 20135/2/2013-0.18
Q4 20122/8/20130.14
Q3 201210/31/2012-0.05
Q2 20127/31/2012-0.01
Q1 20125/2/2012-0.01
NBIX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/4/20220.31B
Q4 20212/11/20220.31B
Q3 202111/1/20210.30B
Q2 20218/3/20210.29B
Q1 20215/5/20210.24B
Q4 20202/4/20210.25B
Q3 202011/9/20200.26B
Q2 20208/3/20200.30B
Q1 20205/6/20200.24B
Q4 20192/4/20200.24B
Q3 201911/4/20190.22B
Q2 20197/29/20190.18B
Q1 20194/29/20190.14B
Q4 20182/5/2019131.49M
Q3 201811/5/2018151.76M
Q2 20187/31/201896.91M
Q1 20184/30/201871.09M
Q4 20172/13/201894.52M
Q3 201711/1/201760.77M
Q2 20178/3/20176.33M
Q1 20175/9/2017NA
Q4 20162/14/2017NA
Q3 201611/2/2016NA
Q2 20168/3/2016NA
Q1 20165/5/201615.00M
Q4 20152/11/2016NA
Q3 201510/29/2015NA
Q2 20157/29/2015NA
Q1 20154/30/201519.77M
Q4 20142/9/2015NA
Q3 201411/3/2014NA
Q2 20148/6/2014NA
Q1 20144/30/2014NA
Q4 201312/31/2013730000
Q3 201310/29/2013729000
Q2 20137/25/2013730000
Q1 20135/2/2013730000
Q4 20122/8/201321.90M
Q3 201210/31/201216.80M
Q2 20127/31/201210.60M
Q1 20125/2/201211.27M
Quotes delayed 20 minutes

Email EnvelopeFree NBIX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Neurocrine Biosciences (NBIX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NBSE Historical Earnings
NDRA Historical Earnings
NEO Historical Earnings
NEOG Historical Earnings
NERV Historical Earnings
NEXI Historical Earnings
NGM Historical Earnings
NKTR Historical Earnings
NKTX Historical Earnings
NLTX Historical Earnings

NBIX Past Earnings Q&A

What was the best and worst NBIX past earnings results?
For Neurocrine Biosciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest NBIX past earnings result in our data set was 1.420/share posted in Q2 2020, while the lowest was in Q1 2019 when NBIX posted -1.120/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when NBIX reported 0.31B in revenue, while the quarter with the lowest revenue in our data set was Q1 2017 at NA of revenue.

  Suggested answer: There are 41 NBIX past earnings results in our data set.

On this page we presented the NBIX past earnings date information for Neurocrine Biosciences. Reviewing that NBIX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2020, when NBIX posted adjusted EPS of 1.420/share. Meanwhile the lowest NBIX past earnings result was in Q1 2019, when NBIX posted adjusted EPS of -1.120/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when NBIX reported 0.31B in revenue, while the smallest revenue quarter was Q1 2017 when NBIX reported NA in revenue.

Any self directed investor doing their due diligence on NBIX or any other given stock can benefit from researching all of the Neurocrine Biosciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Neurocrine Biosciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NBIX. Thanks for visiting, and the next time you need to research NBIX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: VERU Insider Buying, Institutional Holders of WGRO, CNIT Insider Buying.

 

NBIX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.